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among conﬁ   rmed infected persons. 
From 2006 through 2008, the an-
nual CFR for inﬂ  uenza A (H5N1) in 
Egypt ranged from 36% to 55% (3). 
Since January 1, 2009, the CFR in 
Egypt has been 11%. The recent in-
creases in infections among children 
coupled with a decrease in the CFR in 
the most recent 12-month period sug-
gests that the strain of inﬂ  uenza A vi-
rus (H5N1) now circulating in Egypt 
may be becoming less virulent as it 
continues to spread among young 
children, a segment of the population 
that is highly vulnerable to inﬂ  uenza 
infections (4,5).
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Imported 
Chikungunya Virus 
Infection
To the Editor: Chikungunya is 
a disease caused by an arboviral al-
phavirus transmitted to humans by 
Aedes mosquitoes (Aedes aegypti, Ae. 
albopictus). Symptoms include fever, 
myalgia, rash, and joint pain (which 
can last for several months) (1). Dur-
ing the 2005–2006 epidemics on Re-
union Island, clinical manifestations 
such as severe hepatitis, severe ma-
ternal and fetal disease, and meningo-
encephalitis not described previously 
were observed (2). Occurring in an im-
munologically uninfected population, 
this outbreak spread quickly, infecting 
approximately one third of the popula-
tion (266,000 of 775,000 inhabitants) 
(2). The case-fatality rate on Reunion 
Island was estimated to be 1/1,000 cas-
es, with excess deaths observed mainly 
among persons >75 years of age (3).
Chikungunya disease is endemic 
to western, central, eastern, and south-
ern Africa; on Indian Ocean and west 
Paciﬁ  c Ocean islands; and in South-
east Asia (1). Before 2005–2006, no 
outbreak of this disease had been de-
scribed on islands in the Indian Ocean 
(Comoros, Mayotte, Madagascar, 
Reunion Island, Mauritius, and Sey-
chelles). Since the epidemic on Re-
union Island, many imported cases 
caused by this arbovirus have been 
reported elsewhere in areas where the 
disease is not endemic, particularly in 
Europe and the United States.
The main competent vector of 
chikungunya virus, a mosquito, Ae. 
albopictus, is indigenous to Southeast 
Asia and some islands of the western 
Paciﬁ  c and Indian Ocean. The mos-
quito spread to the eastern Paciﬁ  c, 
the Americas, Central Africa (Nige-
ria, Cameroon, Equatorial Guinea 
and Gabon), Europe, and the Middle 
East (4,5). Entomologic studies have 
shown that Ae. albopictus mosquitoes 
can now be found in the southeastern 
part of the United States, Mexico, 
Central and South America, the Ca-
ribbean, the Middle East, Japan, and 
southern Europe (Spain, Italy, Bosnia-
Herzegovina, Croatia, France, Greece, 
the Netherlands, Serbia and Montene-
gro, Slovenia, Switzerland, and Alba-
nia) (4,6). This mosquito has also been 
intercepted in Australia’s seaports 
and is now established in northern 
Queensland (7). 
Ae. aegypti mosquitoes are in-
digenous to Africa and disseminated 
around the tropical and subtropical re-
gions. The southeastern United States, 
the Middle East, Southeast Asia, Pa-
ciﬁ  c and Indian islands, and northern 
Australia are also infested by this 
mosquito. In continental Europe, it 
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Table. Age groups, median ages, and case-fatality ratios for influenza A (H5N1) case-patients, by influenza season, Egypt* 
No. case-patients by age group, y  Influenza season, 
August–July  1–8 9–20 21–30 31–40 41–74 >75
Total no. case-
patients
Median
age, y 
Case-fatality 
ratio 
2005–06 4 4 3 2 0 1 14 18.0 42.8
2006–07 13 5 4 2 0 0 24 6.5 37.5
2007–08 3 2 5 1 1 0 12 23.5 58.3
2008–09 28 1 1 3 0 0 33 3.0 15.1
Total 48 12 13 8 1 1 83 — —
*Age at date of clinical sign onset; data from the World Health Organization (2).LETTERS
has been documented in southern re-
gions but today seems to no longer to 
be present there (8).
Climate change, increasing glo-
balization, and ease of travel could 
favor the continuing spread of mos-
quitoes to nonindigenous habitats, 
expanding the number of regions in 
the world where local transmission 
of vector-borne disease could occur. 
In these countries where competent 
vectors are present, patients coming 
from disease-endemic areas at an early 
stage of infection may import the virus 
and be responsible for locally acquired 
mosquito-transmitted cases of chikun-
gunya. The risk for local transmission 
in these countries is not simply theo-
retical, as shown by the epidemic of 
chikungunya in the county of Emilie-
Romagna, Italy, in which 205 cases 
were identiﬁ   ed between July 4 and 
September 27, 2007 (9). In the United 
States, such secondary transmission of 
vector-borne disease has also been ob-
served with malaria (10).
To determine regions of the 
world at risk for an epidemic of chi-
kungunya virus, we ﬁ  rst listed the im-
ported chikungunya cases (i.e., cases 
diagnosed in nonendemic areas) re-
ported around the world. A literature 
review was undertaken on Medline 
by Pubmed and websites provided 
by the World Health Organization, 
Eurosurveillance, European Center 
for Disease Prevention and Control, 
Health Protection Agency (United 
Kingdom), Institut de Veille Sanitaire 
(France), and the Centers for Dis-
ease Control and Prevention (United 
States) were searched for information 
on imported chikungunya cases. Data 
were then mapped and compared with 
the known and theoretical geograph-
ic distributions of Ae. albopictus 
and  Ae. aegypti mosquitoes around 
the world (online Appendix Figure, 
available from www.cdc.gov/EID/
content/16/1/162-appF.htm)  (4–8). 
This ﬁ  gure shows that imported cas-
es were reported in many countries 
where mosquito vectors for chikun-
gunya virus are well established. 
These facts underscore the need 
for clinicians to consider the possibil-
ity of chikungunya disease in patients 
who experience acute unexplained fe-
ver with joint pain and live in regions 
where mosquito vectors are estab-
lished. The presence of imported cases 
and well-established vectors also con-
ﬁ  rms the need for an active surveil-
lance system; early detection of un-
expected new diseases by physicians 
will enable the timely implementation 
of suitable control measures that can 
interrupt the transmission chain.
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